Drug
Nonsteroidal Antiinflammatory Drug
Nonsteroidal Antiinflammatory Drug is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_2
2
50%
Ph not_applicable
1
25%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 22 (50.0%)
N/A1 (25.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee
NCT05486026
completedphase_1
The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults
NCT04139824
completedphase_2
Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury
NCT00597818
completednot_applicable
Long-term Follow-up of Lichtenstein's Operation Versus Mesh Plug Repair
NCT01637818
Clinical Trials (4)
Showing 4 of 4 trials
NCT05486026Phase 2
Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee
NCT04139824Phase 1
The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults
NCT00597818Phase 2
Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury
NCT01637818Not Applicable
Long-term Follow-up of Lichtenstein's Operation Versus Mesh Plug Repair
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4